Related Experiment Videos
Platelet peripheral-type benzodiazepine receptor in major depression
Journal of Affective Disorders
|April 4, 1995
Summary
Major depression is not linked to changes in peripheral-type benzodiazepine receptors (PBR) in platelets. This study found no significant differences in PBR density or function between depressed patients and healthy controls.
Area of Science:
- Neuroscience
- Endocrinology
- Psychiatry
Background:
- Peripheral-type benzodiazepine receptor (PBR) is crucial for steroidogenesis and responds to stress and endocrine shifts.
- Antidepressants have shown to modulate PBR in rat adrenal and hepatic tissues.
Purpose of the Study:
- To investigate the association between major depression and peripheral-type benzodiazepine receptor (PBR) levels in human platelets.
- To determine if PBR density or function is altered in untreated depressed individuals compared to controls.
Main Methods:
- Platelet PBR density (Bmax) and dissociation constant (kd) were measured in 14 untreated depressed patients and 13 healthy controls.
- Correlation analyses were performed between PBR parameters and depression/anxiety severity scores (HDRS, BDI, HARS).
Main Results:
- No significant differences were observed in platelet PBR Bmax or kd between depressed patients and normal controls.
- No correlation was found between PBR Bmax values and the severity of depression or anxiety symptoms.
Conclusions:
- Major depression does not appear to be associated with alterations in peripheral-type benzodiazepine receptor (PBR) density or function in human platelets.
- Unlike stress and certain anxiety disorders, major depression may not involve changes in PBR.